0001213900-24-030811.txt : 20240405 0001213900-24-030811.hdr.sgml : 20240405 20240405160521 ACCESSION NUMBER: 0001213900-24-030811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240403 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazur Leonard L CENTRAL INDEX KEY: 0001463414 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38174 FILM NUMBER: 24826462 MAIL ADDRESS: STREET 1: C/O CITIUS PHARMACEUTICALS, INC. STREET 2: 11 COMMERCE DRIVE, 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001506251 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 273425913 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: (908) 967-6676 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: Trail One, Inc. DATE OF NAME CHANGE: 20110314 FORMER COMPANY: FORMER CONFORMED NAME: TrailOne, Inc. DATE OF NAME CHANGE: 20101119 4 1 ownership.xml X0508 4 2024-04-03 0 0001506251 Citius Pharmaceuticals, Inc. CTXR 0001463414 Mazur Leonard L C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016 1 1 1 0 Chief Executive Officer 0 Common Stock 10255343 D Warrant to Purchase Common Stock 1.42 2024-04-03 4 D 0 1165048 D 2024-04-05 Common Stock 1165048 0 D Warrant to Purchase Common Stock 1.42 2024-04-03 4 A 0 1165048 A 2025-04-05 Common Stock 1165048 1165048 D Stock Option (Right to Purchase Common Stock) 0.70 2033-10-10 Common Stock 550000 550000 D Stock Option (Right to Purchase Common Stock) 1.25 2032-10-04 Common Stock 550000 550000 D Stock Option (Right to Purchase Common Stock) 2.04 2031-10-11 Common Stock 650000 650000 D Stock Option (Right to Purchase Common Stock) 2.00 2031-07-22 Common Stock 300000 300000 D Stock Option (Right to Purchase Common Stock) 1.01 2030-10-06 Common Stock 200000 200000 D Stock Option (Right to Purchase Common Stock) 0.67 2029-10-08 Common Stock 175000 175000 D Warrant to Purchase Common Stock 0.77 2024-09-27 Common Stock 2234700 2234700 D Stock Option (Right to Purchase Common Stock) 1.62 2028-09-04 Common Stock 150000 150000 D Warrant to Purchase Common Stock 1.15 2024-08-14 Common Stock 3137255 3137255 D Stock Option (Right to Purchase Common Stock) 6.75 2024-09-12 Common Stock 220000 220000 D Stock Option (Right to Purchase Common Stock) 3.45 2027-09-13 Common Stock 40000 40000 D The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately. The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date. The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date The options vested in full on October 6, 2023. The options vested in full on October 8, 2022. The warrant is fully vested and exercisable immediately. The options vested in full on September 4, 2021 The options vested in full on September 12, 2017. The options vested in full on September 13, 2020. /s/ Alexander M. Donaldson, by power of attorney 2024-04-05